BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2020 5:49:13 AM | Browse: 701 | Download: 1153
 |
Received |
|
2020-05-15 06:37 |
|
Peer-Review Started |
|
2020-05-15 06:38 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-06-03 17:35 |
|
Revised |
|
2020-06-10 14:05 |
|
Second Decision |
|
2020-07-16 12:12 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-07-19 20:41 |
|
Articles in Press |
|
2020-07-19 20:41 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-07-24 22:36 |
|
Typeset the Manuscript |
|
2020-08-20 10:23 |
|
Publish the Manuscript Online |
|
2020-08-26 05:49 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cell Biology |
| Manuscript Type |
Review |
| Article Title |
Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Panagiotis Mallis, Efstathios Michalopoulos, Theofanis Chatzistamatiou and Catherine Stavropoulos-Giokas |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Panagiotis Mallis, MSc, PhD, Associate Research Scientist, Teaching Assistant, Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, Athens 11527, Greece. pmallis@bioacademy.gr |
| Key Words |
SARS-CoV-2; COVID-19; Respiratory syndrome; Cytokine storm; Mesenchymal stromal cells; Immunoregulation |
| Core Tip |
In this review, the therapeutic potential of mesenchymal stromal cells (MSCs) towards coronavirus disease-19 (COVID-19), will be highlighted. Importantly, MSCs exert key immunoregulatory/immunosuppressive properties which can alter significantly the immune responses. Also, MSCs share regenerative abilities, reducing in this way the lung tissue damage. These unique MSCs features, which may significantly improve the overall condition of COVID-19 patients, will be presented in the following article. |
| Publish Date |
2020-08-26 05:49 |
| Citation |
Mallis P, Michalopoulos E, Chatzistamatiou T, Stavropoulos-Giokas C. Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection. World J Stem Cells 2020; 12(8): 731-751 |
| URL |
https://www.wjgnet.com/1948-0210/full/v12/i8/731.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v12.i8.731 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
